Concepedia

Peter A. Prieto

PA

28

Publications

8.6K

Citations

17

H-Index

2010

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Rochester Medical Center

National Cancer Institute

National Institutes of Health

Baylor College of Medicine

Peter A. Prieto is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, immunology, and oncology.

ORCID

Top concepts

Publications per year

2010–2024

28

Publications

28

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

Vancheswaran Gopalakrishnan, Christine N. Spencer, Luigi Nezi et al. · Science · 2017 · 4.4K citations · Full text

Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

Pei-Ling Chen, Whijae Roh, Alexandre Reuben et al. · Cancer Discovery · 2016 · 971 citations · Full text

Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance

Whijae Roh, Pei-Ling Chen, Alexandre Reuben et al. · Science Translational Medicine · 2017 · 902 citations · Full text

, , +18

CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma

Peter A. Prieto, James Chih‐Hsin Yang, Richard M. Sherry et al. · Clinical Cancer Research · 2012 · 474 citations · Full text

Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

Miles C. Andrews, Connie P.M. Duong, Vancheswaran Gopalakrishnan et al. · Nature Medicine · 2021 · 388 citations · Full text

, , +13

Rows per page

1–5 of 28